top of page
For the modern human
Unleashing the power of personalised glucose

Comfortable wearable technology with real-time insights to help you feel and live your best for longer.

Read more
Read more
Read more



$3M raised so far


Patents-pending in 6 regions

Opuz overcomes roadblocks that prevent competitors from reaching the gold standard
Rich, reliable, real-time insights
Personalised for you
Enhance well-being
Gain insight into your unique glucose needs to stay enegetic and give your best at work and at home for loved ones.
Optimise sport output
Understand your body's energy consumption so you can optimise endurance, recovery, and competition strategy for peak performance.
Age with vitality
Receive age-specific insights and friendly reminders that can be shared, so you can have peace of mind while playing hard.
Practise sustainable health
Be supported with a wealth of knowledge for consistent glucose levels supporting your healthy and vibrant future.
There's never been a wearable like this

Elegant designs blending seamlessly into your lifestyle

While the current design is in a ring form, we are also experimenting with sleek wrist and patch forms to suit all users.

4-sensor systeims powering clinician-trained AI

Our clinicians use the raw biodata captured from the skin to calculate and calibrate for accuracy to provide meaningful actionable insights.

Customisable app to see the insights that matter to you

Integrating with both iOS and Android ecosytems, choose from dashboards that reflect your individual needs and goals.

Clinically validated for safe and reliable use

Backed by science and ongoing trials, Opuz technology demonstrates safety and efficacy through published peer-reviewed research.

“The 2021 human trial study result demonstrated that continued development of the Opuz prototype is warranted, progressing toward a miniaturised wearable while conducting further clinical studies aimed at generating large volumes of accurate blood glucose level data with a broad spread from hypoglycemia to hyperglycemia ranges.”

Dr. Stephen Calagiuri, MB.BS (Honours Class II) FRACP Professor of Metabolic Health, The University of Sydney

bottom of page